Form D · Other Health Care
AxoGen, Inc.
Texarkana, TX · CIK 0000805928
Offering snapshot reported Oct 13, 2011 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2011 | Initial | $1,000,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-167184
Source: Form D, filed Oct 13, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John P. Engels | Executive |
| Gregory G. Freitag | Director, Executive |
| Mark Friedman | Executive |
| Mark Gold | Director |
| Jamie M. Grooms | Director |
| David Hansen | Executive |
| John Harper | Director |
| Brad Hedger | Executive |
| Joe Mandato | Director |
| Robert J. Rudelius | Director |
| Karen Zaderej | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1407 S. Kings Highway
Texarkana, TX, 75501
Texarkana, TX, 75501